Needham Reiterates Buy on Merit Medical Systems, Maintains $96 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a 'Buy' rating on Merit Medical Systems (NASDAQ:MMSI) and maintained a price target of $96.
September 27, 2023 | 9:25 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Merit Medical Systems has received a reiterated 'Buy' rating from Needham analyst Mike Matson, with a maintained price target of $96.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. A reiterated 'Buy' rating indicates that the analyst continues to have a positive outlook on the company, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100